title: Effect of acute hyperhomocysteinemia on methylation potential of erythrocytes and on DNA methylation of lymphocytes in healthy male volunteers.
abstract: Homocysteine is a precursor of S-adenosylmethionine (AdoMet) and a metabolite of S-adenosylhomocysteine (AdoHcy). The ratio of AdoMet to AdoHcy, defined as the methylation potential (MP), indicates the flow of methyl groups within the cells. Chronic elevations of total homocysteine (tHcy) in plasma correlate with increased AdoHcy concentrations, decreased MP, and impaired DNA methylation. However, the influence of acute hyperhomocysteinemia on MP is unknown. We induced acute hyperhomocysteinemia in 14 healthy volunteers by oral administration of l-homocysteine (65.1 micromol/kg body wt) in an open, randomized, placebo-controlled two-period crossover study. The kinetics of tHcy in blood and urine, MP in blood, and global DNA methylation in lymphocytes were studied systematically during 48 h. Plasma tHcy concentrations reached a peak at 34 +/- 11 min after an oral load with l-homocysteine and decreased with a half-life of 257 +/- 41 min (means +/- SD). Only 2.3% of the homocysteine dose were recovered in urine. AdoHcy concentrations and MP in whole blood and erythrocytes were not affected by the oral homocysteine load. Furthermore, global DNA methylation in lymphocytes did not change under these conditions. We found no difference between the genotypes of 5,10-methylenetetrahydrofolate reductase in response to the homocysteine load. However, AdoMet content in erythrocytes was significantly higher in the C677T carriers (CT; n = 7) compared with the CC genotype (n = 7). Although chronic elevation of tHcy has been shown to affect MP and DNA methylation, acute elevation of plasma tHcy above 20 micromol/l for 8 h is not sufficient to change MP and to induce DNA hypomethylation in lymphocytes.
authors.affiliation: Dept. of Pharmacology and Toxicology, Div. of Experimental Pharmacology, Univ. Hospital Tübingen, Wilhelmstr. 56, D-72074 Tübingen, Germany. hartmut.osswald@uni-tuebingen.de
authors.forename: R
authors.initials: R
authors.lastname: Fux
authors.forename: D
authors.initials: D
authors.lastname: Kloor
authors.forename: M
authors.initials: M
authors.lastname: Hermes
authors.forename: T
authors.initials: T
authors.lastname: Röck
authors.forename: B
authors.initials: B
authors.lastname: Proksch
authors.forename: A
authors.initials: A
authors.lastname: Grenz
authors.forename: U
authors.initials: U
authors.lastname: Delabar
authors.forename: R
authors.initials: R
authors.lastname: Bücheler
authors.forename: S
authors.initials: S
authors.lastname: Igel
authors.forename: K
authors.initials: K
authors.lastname: Mörike
authors.forename: C H
authors.initials: CH
authors.lastname: Gleiter
authors.forename: H
authors.initials: H
authors.lastname: Osswald
mesh_terms: D000328:Adult; D018592:Cross-Over Studies; D019175:DNA Methylation / Q000187:drug effects*; D004912:Erythrocytes / Q000378:metabolism*; D005838:Genotype; D006207:Half-Life; D006579:Heterozygote; D006710:Homocysteine / Q000097:blood* / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D007444:Inulin; D007700:Kinetics; D008214:Lymphocytes / Q000378:metabolism*; D008297:Male; D012436:S-Adenosylmethionine / Q000097:blood
chemical_list: D006710:Homocysteine; D012436:S-Adenosylmethionine; D007444:Inulin